All In MedTech

FDA Clearance Tracker · P100044-S020

PROPEL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 24, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 24, 2016

Approved

Time to decision

152 days

Received Mar 25, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100044-S020
Device name
PROPEL
Applicant location
Menlo Park, CA
Received
Mar 25, 2016
Decided
Aug 24, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100044

Device type

Device class
Class III

Every decision under product code OWO

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Synergy Health AST, LLC, Lakevillle Hwy, Suite 120, Petaluma, CA 94954 as a backup sterilization facility for the Propel and Propel Mini Sinus Implants.

Source documents

Other decisions for Intersect Ent.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.